Literature DB >> 11686340

Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).

C Kositchaiwat, A Chuansumrit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686340

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  2 in total

1.  Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa.

Authors:  Ayse L Mindikoglu; Abhinandana Anantharaju; Magdalene George; Nikunj N Shah; Jaime Villanueva; David H van Thiel
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

2.  Use of recombinant factor VIIa to correct the coagulation status of individuals with advanced liver disease prior to a percutaneous liver biopsy.

Authors:  Shabbar Sajjad; Moises Garcia; Ahmed Malik; Magdalena M George; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2009-03-14       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.